Nipah virus

Nipah virus
Name	Nipah virus
Virus group	Paramyxoviridae, Henipavirus
Genome	Negative-sense single-stranded RNA
Hosts	Pteropus fruit bats, humans, swine, other mammals
Diseases	Encephalitis, respiratory disease

Nipah virus. Nipah virus is a zoonotic paramyxovirus associated with severe encephalitis and respiratory illness that emerged in Southeast Asia; it is a member of the Henipavirus genus related to Hendra virus and other paramyxoviruses known from Australia and Asia. Early identification involved collaborations among researchers at institutions such as the Centers for Disease Control and Prevention, World Health Organization, and regional public health agencies in Malaysia, Singapore, and Bangladesh. Clinical management and public health responses have engaged specialist facilities including Johns Hopkins Hospital, Royal Darwin Hospital, and national reference laboratories in India and Thailand.

Taxonomy and Virology

Nipah virus belongs to the family Paramyxoviridae and genus Henipavirus, sharing structural and genetic features with Hendra virus and relating to historical paramyxovirus work at laboratories like the Commonwealth Scientific and Industrial Research Organisation and the National Institutes of Health. The virus has a negative-sense single-stranded RNA genome encoding nucleocapsid, phosphoprotein, matrix, fusion, glycoprotein and polymerase proteins, described using methods developed at the Sanger Institute and sequenced with platforms pioneered by groups at Illumina and the Broad Institute. Electron microscopy studies performed with equipment in facilities such as The Francis Crick Institute and Cold Spring Harbor Laboratory show pleomorphic enveloped virions with surface glycoproteins analogous to those characterized for Measles virus and Mumps virus. Molecular phylogenetics places Nipah virus in clades that have been compared using algorithms from researchers at University of California, Berkeley, Massachusetts Institute of Technology, and University of Oxford to understand relationships with bat-borne paramyxoviruses documented in surveys by teams from Harvard University and the Australian National University.

Transmission and Epidemiology

Transmission is primarily zoonotic from reservoir hosts, notably flying foxes of the genus Pteropus documented in field studies by ecologists affiliated with Smithsonian Institution, Zoological Society of London, and Bangladesh Institute of Tropical and Infectious Diseases. Outbreaks have involved intermediate amplifying hosts such as domestic pigs in episodes investigated by veterinary services in Malaysia and surveillance teams from World Organisation for Animal Health. Human-to-human transmission has been reported in healthcare settings referenced in case reports from King George's Medical University, Apollo Hospitals, and public health investigations coordinated by Public Health England and Health Protection Agency-era institutions. Epidemiologic patterns have been analyzed with models developed at Imperial College London, London School of Hygiene & Tropical Medicine, and École Polytechnique Fédérale de Lausanne to estimate reproductive numbers, serial intervals, and risk factors related to agricultural practices in regions including Kerala, Sylhet, and Perak.

Clinical Presentation and Diagnosis

Clinical presentation ranges from acute febrile encephalitis to severe respiratory syndrome; descriptions in case series published by clinicians at Mayo Clinic, All India Institute of Medical Sciences, and Chulalongkorn University detail symptoms including altered mental status, seizures, cough, and pulmonary edema. Diagnostic confirmation relies on molecular assays such as RT-PCR assays developed with protocols from Centers for Disease Control and Prevention and validated by reference centers at National Institute of Virology (India) and the Pasteur Institute network, and serology using ELISA platforms standardized by laboratories at National Institute of Allergy and Infectious Diseases and commercial partners like Roche. Neuroimaging findings reported by radiology departments at Guy's and St Thomas' NHS Foundation Trust and Mayo Clinic include diffuse cerebral edema and signal changes in basal ganglia, while pathology studies from autopsies conducted in collaboration with pathologists at Karolinska Institutet and University of Tokyo describe vasculitis and neuronal necrosis.

Treatment and Prevention

There is no universally approved specific antiviral therapy; clinical care has relied on supportive intensive care in units such as those at Royal Melbourne Hospital and oxygenation strategies used in protocols from American Thoracic Society and European Society of Intensive Care Medicine. Experimental therapeutics investigated include monoclonal antibodies and small molecules evaluated in preclinical models at National Institutes of Health, Walter Reed Army Institute of Research, and vaccine-challenge studies reported by teams at Rockefeller University and Duke University. Prevention strategies center on One Health approaches coordinated by World Health Organization, Food and Agriculture Organization, and World Organisation for Animal Health including bat surveillance, pig herd management protocols promoted by Department of Veterinary Services (Malaysia), and community interventions implemented by BRAC and local ministries of health in affected regions.

History and Outbreaks

The virus was first recognized during an outbreak of encephalitis and respiratory disease among pig farmers and abattoir workers in Sungai Nipah and Kuala Lumpur in 1998–1999, triggering multinational investigations involving teams from University of Malaya, Centers for Disease Control and Prevention, and World Health Organization. Subsequent annual and sporadic outbreaks have occurred in Bangladesh with links to consumption of date palm sap documented by epidemiologists from icddr,b, and in India with notable events in West Bengal and Kerala investigated by state public health departments and research groups at National Institute of Virology (India). International incident responses have included coordination with agencies such as Médecins Sans Frontières, USAID, and regional laboratories in Singapore General Hospital and Tan Tock Seng Hospital.

Research and Vaccine Development

Research into vaccines and therapeutics has been pursued by consortia including academic groups at University of Oxford, Harvard Medical School, and industry partners such as GlaxoSmithKline and Moderna exploring platforms from subunit vaccines to mRNA technologies. Preclinical vaccine candidates using G glycoprotein immunogens and vectored platforms have shown efficacy in nonhuman primate models in studies led by investigators at National Institutes of Health and Canadian Institutes of Health Research, and monoclonal antibody therapies have advanced through trials coordinated with regulatory authorities including US Food and Drug Administration and European Medicines Agency. Ongoing surveillance, ecological studies by teams at Australian Centre for Disease Preparedness and pathogen discovery efforts at Wellcome Sanger Institute continue to inform risk assessment, while collaborative networks such as CEPI and the Coalition for Epidemic Preparedness Innovations support accelerated development and equitable access strategies.

Category:Paramyxoviridae